CSP maintains principal buyer status across all manufacturer relationships.
Every relationship is direct, approved, and active — no brokers, no grey market, no compromised provenance.
48 manufacturer relationships. Syringes, IV sets, infusion pumps, needles.
42 relationships. Oxygen concentrators, ventilators, anaesthesia machines.
38 relationships. Surgical packs, instruments, sutures, sterilization.
35 relationships. Patient monitors, pulse oximeters, ECG, blood pressure.
32 relationships. Dressings, disinfectants, gloves, infection control.
28 relationships. IV solutions, essential medicines, cold chain pharma.
22 relationships. Trauma kits, defibrillators, emergency supplies.
16 relationships. Incubators, phototherapy, delivery kits, neonatal care.
CSP operates as a principal buyer — not a distributor, agent, or broker. The company holds direct approved commercial relationships with manufacturers, purchasing and reselling as a principal. This means every product carries full manufacturer authority, clinical traceability, and regulatory integrity with zero intermediaries in the supply chain.
For manufacturers, this provides a single point of entry into 22 African and Middle Eastern markets with instant settlement, embedded compliance, and demand visibility through AI-matched clinical specifications.
Direct access to 22 markets. Instant settlement. Zero intermediary fees.